Portrazza (Necitumumab), an IgG1 Monoclonal Antibody, FDA Approved for Advanced Squamous Non-Small-Cell Lung Cancer.
Loretta
L
Fala
J Clin Oncol. 2014 Nov 10;32(32):3673-9
25311215
Lancet Oncol. 2015 Mar;16(3):328-37
25701171
Lancet Oncol. 2015 Jul;16(7):763-74
26045340